by Brandon Tudor | Mar 5, 2026 | Blog
From 02/23/2026, an article that highlights the overlap between kidney stones and MASLD: “Association between metabolic dysfunction-associated steatotic liver disease and kidney stone risk in individuals with metabolic dysfunction: evidence from cross-sectional...
by Brandon Tudor | Mar 2, 2026 | Blog
A summary of the Clinical Gastroenterology and Hepatology article with DOI S1542-3565(24)00989-3, titled Food Swamps and Food Deserts Impact on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) follows.It speaks to how Liver Disease triage, diagnosis...
by Brandon Tudor | Feb 23, 2026 | Blog
Here are the top 10 liver-related events (LREs) commonly used in clinical research and outcome studies of chronic liver disease. “LREs” refer to major clinical complications and outcomes that indicate progression of liver disease and substantially impact prognosis,...
by Brandon Tudor | Feb 19, 2026 | Blog
Comparison between traditional hepatobiliary surgery for HCC and HistoSonics’ Edison (histotripsy). 1) What “traditional hepatobiliary surgery for HCC” usually means A. Curative-intent surgery Partial hepatectomy (liver resection): Remove the tumor-bearing portion of...
by Brandon Tudor | Feb 15, 2026 | Blog
Ways to frame liver disease symptoms There are two key categories: 1) Usually no symptoms earlyFatty liver disease often has no noticeable symptoms until it progresses. Most people are diagnosed via routine blood tests or imaging, not symptoms. 2) Possible...